Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?

Albemarle ALB is set to release its second-quarter earnings report on July 31. Here’s Morningstar’s take on what to look for in Albemarle’s earnings and the outlook for its stock.

Key Morningstar Metrics for Albemarle

• Fair Value Estimate: $275.00
• Morningstar Rating: 5 stars
• Morningstar Economic Moat Rating: Narrow
• Morningstar Uncertainty Rating: High

Earnings Release Date

• July 31, after the close of trading

What to Watch for in Albemarle’s Q2 Earnings

• Realized lithium prices: Lithium prices are the key driver of profits and market sentiment around Albemarle’s stock. Index prices were roughly flat during the second quarter versus the first, but we will see how Albemarle’s realized prices evolved.
• Lithium volumes: Albemarle has been ramping up new lithium projects. We will read volume growth during the second quarter as a sign of Albemarle’s progress toward finishing these projects.
• Lithium (energy storage segment) costs: Albemarle’s new projects will temporarily inflate its unit production costs until those operations are fully ramped. We believe declining costs could have started as early as this past quarter. Albemarle’s ability to reduce unit production costs is its second-largest profit driver. We will see how the firm’s unit costs evolved during the quarter.
• Capital expenditures: Albemarle has been delaying new capacity in response to cyclically low lithium prices to reduce capital expenditures. We await management’s outlook for new projects and news on whether Albemarle will further cut capex in 2025 to generate positive free cash flow.

Fair Value Estimate for Albemarle

With its 5-star rating, we believe Albemarle’s stock is significantly undervalued compared with our long-term fair value estimate of $275 per share. We assume roughly a 10% weighted average cost of capital. We use a multiple of 11.5 times midcycle EBITDA to value free cash flows generated beyond our 10-year explicit forecast.

The bulk of the growth will come from lithium. We expect contract lithium prices will rise in 2024. Lithium carbonate spot prices, which tend to be a leading indicator of contract prices, are currently around $14,300 per metric ton (based on published indexes), down from $75,000 at the end of 2022 but up from the multiyear low of $13,500 in February. Prices fell due to slowing lithium purchases as a result of inventory destocking. However, as demand growth remains strong and outpaces supply, we expect prices to remain stable in the first half of 2024 and rise in the second half.

Read more about Albemarle’s fair value estimate.

Economic Moat Rating

We award Albemarle a narrow moat based on its strong and durable cost advantage in lithium and bromine production. Globally, lithium carbonate is produced from either lower-cost brine evaporation or higher-cost mining of spodumene minerals. Albemarle has a cost advantage in lithium carbonate production due to its lucrative brine assets in the Salar de Atacama in Chile, which produces lithium at the lowest cost globally, excluding royalties.

Read more about Albemarle’s economic moat.

Financial Strength

Albemarle is in good financial health. As of March 31, management reported net debt/adjusted EBITDA was 0.9 times, well below management’s long-term target of less than 2.5. The firm plans to invest heavily over the next few years to expand its upstream and downstream lithium production volumes. It plans to expand its lithium refining capacity largely through the buildout of brownfield capacity and new greenfield spodumene conversion plants in China. While these expansions will likely be capital-intensive, they should be cheaper than building new greenfield lithium production assets in higher-cost regions like Australia.

Read more about Albemarle’s financial strength.

Risk and Uncertainty

We assign Albemarle a High Uncertainty Rating. The company’s biggest risk is volatile lithium prices. Prices could decline if EV demand grows more slowly than expected or new low-cost supply ramps up quicker than demand. New batteries, such as sodium-ion, could overtake lithium as the preferred energy storage resource.

Lithium production could ramp up more quickly than demand warrants if producers bring too much supply to the market. Further, new lithium production technologies could alter the cost curve in carbonate and hydroxide. Albemarle faces execution risk in ramping up its lithium production, which includes production delays and cost overruns.

Albemarle is also subject to political risk, especially in Chile. In President Gabriel Boric’s announced plan to nationalize lithium, the Chilean government would own a majority stake in all projects. If this occurs, Albemarle could be forced to sell a 50.1% stake to the Chilean government at a price as low as asset book value to extend its lease when it expires in 2043.

Read more about Albemarle’s risk and uncertainty.

ALB Bulls Say

• Albemarle has top-tier lithium assets through its brine operations in Chile and spodumene hard-rock operations in Western Australia, among the lowest-cost sources of lithium production globally.
• Lithium prices should remain well above the marginal cost of production through at least the remainder of the decade, leading to excess profits and return on invested capital for Albemarle.
• Albemarle has low-cost bromine production through its highly concentrated brines in the Dead Sea and Arkansas.

ALB Bears Say

• Lithium prices will fall if new supply comes online faster than demand, weighing on profitability. Albemarle’s plans to increase its lithium production capacity would prove value-destructive amid lower prices.
• Albemarle’s bromine business will decline from weak demand for flame retardants as consumers shift from computers to less bromine-intensive tablets and smartphones.
• Chile’s plan to nationalize lithium could result in Albemarle being forced to sell a majority stake to the government at a price around asset book value, destroying shareholder value.

This article was compiled by Leona Murray.